Literature DB >> 13904589

Studies on the role of intravascular coagulation in irreversible hemorrhagic shock.

R M HARDAWAY, W H BRUNE, E F GEEVER, J W BURNS, H P MOCK.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION/physiology; SHOCK/experimental

Mesh:

Year:  1962        PMID: 13904589      PMCID: PMC1466037          DOI: 10.1097/00000658-196200000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  Intravascular thrombi and the intestinal factor of irreversible shock.

Authors:  R M HARDAWAY; D G McKAY
Journal:  Ann Surg       Date:  1959-08       Impact factor: 12.969

2.  Studies on pH changes in endotoxin and hemorrhagic shock.

Authors:  R M HARDAWAY; T G BARILA; J W BURNS; H P MOCK
Journal:  J Surg Res       Date:  1961-11       Impact factor: 2.192

3.  Intracapillary clotting as the etiology of shock.

Authors:  R M HARDAWAY; F H WEISS
Journal:  Arch Surg       Date:  1961-12

4.  Precipitation of human fibrinogen with heparin.

Authors:  H C GODAL
Journal:  Scalpel (Brux)       Date:  1960

5.  Alterations in blood coagulation mechanism after intra-aortic injection of thrombin.

Authors:  R M HARDAWAY; H E WATSON; F H WEISS
Journal:  Arch Surg       Date:  1960-12

6.  Disseminated intravascular coagulation: a cause of shock.

Authors:  R M HARDAWAY; D G McKAY
Journal:  Ann Surg       Date:  1959-04       Impact factor: 12.969

7.  Alterations in blood coagulation mechanism after incompatible blood transfusion; clinical and experimental observations.

Authors:  D G McKAY; R M HARDAWAY; G H WAHLE; R EDELSTEIN; D E TARTOCK
Journal:  Am J Surg       Date:  1955-03       Impact factor: 2.565

  7 in total
  29 in total

1.  THE ROLE OF MICRO-EMBOLISM IN THE PRODUCTION OF IRREVERSIBLE SHOCK.

Authors:  H J ROBB
Journal:  Ann Surg       Date:  1963-10       Impact factor: 12.969

2.  STUDIES ON THE FIBRINOGEN REPLACEMENT RATE IN DOGS.

Authors:  R M HARDAWAY; D G JOHNSON; M J ELOVITZ; D N HOUCHIN; E B JENKINS; J W BURNS; D R JACKSON
Journal:  Ann Surg       Date:  1964-11       Impact factor: 12.969

3.  Mechanism of action of fibrinolysin in the prevention of irreversible hemorrhagic shock.

Authors:  R M HARDAWAY; J W BURNS
Journal:  Ann Surg       Date:  1963-02       Impact factor: 12.969

4.  Prevention of "irreversible" hemorrhagic shock with fibrinolysin.

Authors:  R M HARDAWAY; D C DRAKE
Journal:  Ann Surg       Date:  1963-01       Impact factor: 12.969

5.  Role of norepinephrine in irreversible hemorrhagic shock.

Authors:  R M HARDAWAY; R E NEIMES; J W BURNS; H P MOCK; P T TRENCHAK
Journal:  Ann Surg       Date:  1962-07       Impact factor: 12.969

6.  The role of intravascular clotting in the etiology of shock.

Authors:  R M HARDAWAY
Journal:  Ann Surg       Date:  1962-03       Impact factor: 12.969

7.  Role of the canine spleen in irreversible hemorrhagic shock.

Authors:  R M HARDAWAY; R E NEIMES; J W BURNS; H P MOCK; P T TRENCHAK
Journal:  Ann Surg       Date:  1962-08       Impact factor: 12.969

8.  Patterns of Intestinal Ischaemia: Arris and Gale Lecture delivered at the Royal College of Surgeons of England on 6th February 1964.

Authors:  A Marston
Journal:  Ann R Coll Surg Engl       Date:  1964-09       Impact factor: 1.891

Review 9.  Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications.

Authors:  Hunter B Moore; Ernest E Moore; Matthew D Neal; Forest R Sheppard; Lucy Z Kornblith; Dominik F Draxler; Mark Walsh; Robert L Medcalf; Mitch J Cohen; Bryan A Cotton; Scott G Thomas; Christine M Leeper; Barbara A Gaines; Angela Sauaia
Journal:  Anesth Analg       Date:  2019-09       Impact factor: 5.108

10.  The "Death Diamond": Rapid thrombelastography identifies lethal hyperfibrinolysis.

Authors:  Michael P Chapman; Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Alexander P Morton; James Chandler; Courtney D Fleming; Arsen Ghasabyan; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2015-12       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.